Nanotechnology-based Fungal Detection and Treatment: Current Status and Future Perspective

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2023 Aug 19

PMID 37597093

Authors

Vinay Chaudhari

Vaishnavi Vairagade

Ami Thakkar

Himani Shende

Amisha Vora

Affiliations

Soon will be listed here.

Abstract

Fungal infections impose a significant impact on global health and encompass major expenditures in medical treatments. Human mycoses, a fungal co-infection associated with SARS-CoV-2, is caused by opportunistic fungal pathogens and is often overlooked or misdiagnosed. Recently, there is increasing threat about spread of antimicrobial resistance in fungus, mostly in hospitals and other healthcare facilities. The diagnosis and treatment of fungal infections are associated with several issues, including tedious and non-selective detection methods, the growth of drug-resistant bacteria, severe side effects, and ineffective drug delivery. Thus, a rapid and sensitive diagnostic method and a high-efficacy and low-toxicity therapeutic approach are needed. Nanomedicine has emerged as a viable option for overcoming these limitations. Due to the unique physicochemical and optical properties of nanomaterials and newer biosensing techniques, nanodiagnostics play an important role in the accurate and prompt differentiation and detection of fungal diseases. Additionally, nano-based drug delivery techniques can increase drug permeability, reduce adverse effects, and extend systemic circulation time and drug half-life. This review paper is aimed at highlighting recent, promising, and unique trends in nanotechnology to design and develop diagnostics and treatment methods for fungal diseases.

Citing Articles

Polyene-Based Derivatives with Antifungal Activities.

Ngece K, Ntondini T, Khwaza V, Paca A, Aderibigbe B Pharmaceutics. 2024; 16(8).

PMID: 39204411 PMC: 11360744. DOI: 10.3390/pharmaceutics16081065.

References

Jose P, Raja J, Sankarganesh M, Rajesh J . Evaluation of antioxidant, DNA targeting, antimicrobial and cytotoxic studies of imine capped copper and nickel nanoparticles. J Photochem Photobiol B. 2017; 178:143-151. DOI: 10.1016/j.jphotobiol.2017.11.005. View

Alhowyan A, Altamimi M, Kalam M, Khan A, Badran M, Binkhathlan Z . Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies. J Microbiol Methods. 2019; 161:87-95. DOI: 10.1016/j.mimet.2019.01.020. View

Ali M, Afzal M, Bhattacharya S, Ahmad F, Dinda A . Nanopharmaceuticals to target antifilarials: a comprehensive review. Expert Opin Drug Deliv. 2013; 10(5):665-78. DOI: 10.1517/17425247.2013.771630. View

Althagafi I, Ahmed S, El-Said W . Fabrication of gold/graphene nanostructures modified ITO electrode as highly sensitive electrochemical detection of Aflatoxin B1. PLoS One. 2019; 14(1):e0210652. PMC: 6334944. DOI: 10.1371/journal.pone.0210652. View

Alzayyat S, Almutiri G, Aljandan J, Algarzai R, Khan S, Akhtar S . Antifungal Efficacy and Physical Properties of Poly(methylmethacrylate) Denture Base Material Reinforced with SiO Nanoparticles. J Prosthodont. 2020; 30(6):500-508. DOI: 10.1111/jopr.13271. View

Asghar W, Sher M, Khan N, Vyas J, Demirci U . Microfluidic Chip for Detection of Fungal Infections. ACS Omega. 2019; 4(4):7474-7481. PMC: 6504191. DOI: 10.1021/acsomega.9b00499. View

Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E . The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2011; 119(8):1831-7. DOI: 10.1182/blood-2011-04-351601. View

Bhanuprasad K, Manesh A, Devasagayam E, Varghese L, Cherian L, Kurien R . Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic. Int J Infect Dis. 2021; 111:267-270. PMC: 8383616. DOI: 10.1016/j.ijid.2021.08.037. View

Bhatnagar I, Mahato K, Ealla K, Asthana A, Chandra P . Chitosan stabilized gold nanoparticle mediated self-assembled gliP nanobiosensor for diagnosis of Invasive Aspergillosis. Int J Biol Macromol. 2017; 110:449-456. DOI: 10.1016/j.ijbiomac.2017.12.084. View

10.

Brunet K, Alanio A, Lortholary O, Rammaert B . Reactivation of dormant/latent fungal infection. J Infect. 2018; 77(6):463-468. DOI: 10.1016/j.jinf.2018.06.016. View

11.

Buzea C, Pacheco I, Robbie K . Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2010; 2(4):MR17-71. DOI: 10.1116/1.2815690. View

12.

Carlson M, Bargeron C, Benson R, Fraser A, Phillips T, Velky J . An automated, handheld biosensor for aflatoxin. Biosens Bioelectron. 2000; 14(10-11):841-8. DOI: 10.1016/s0956-5663(99)00057-3. View

13.

Chakrabarti A, Sood P, Rudramurthy S, Chen S, Kaur H, Capoor M . Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2014; 41(2):285-95. DOI: 10.1007/s00134-014-3603-2. View

14.

Chatterjee K, Taneja J, Khullar S, Pandey A . Antifungal activity of silver nanoparticles on fungal isolates from patients of suspected mucormycosis. Int Microbiol. 2022; 26(1):143-147. PMC: 9574810. DOI: 10.1007/s10123-022-00280-7. View

16.

Cornely O, Alastruey-Izquierdo A, Arenz D, Chen S, Dannaoui E, Hochhegger B . Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019; 19(12):e405-e421. PMC: 8559573. DOI: 10.1016/S1473-3099(19)30312-3. View

17.

Cox M, Loman N, Bogaert D, OGrady J . Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020; 1(1):e11. PMC: 7195315. DOI: 10.1016/S2666-5247(20)30009-4. View

18.

Farooq M, Usman F, Zaib S, Saeed Shah H, Jamil Q, Sheikh F . Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity. Molecules. 2022; 27(10). PMC: 9144605. DOI: 10.3390/molecules27103347. View

19.

Fauci A, Lane H, Redfield R . Covid-19 - Navigating the Uncharted. N Engl J Med. 2020; 382(13):1268-1269. PMC: 7121221. DOI: 10.1056/NEJMe2002387. View

20.

Fu P, Xia Q, Hwang H, Ray P, Yu H . Mechanisms of nanotoxicity: generation of reactive oxygen species. J Food Drug Anal. 2014; 22(1):64-75. PMC: 9359151. DOI: 10.1016/j.jfda.2014.01.005. View

21.

Fukui H, Koike T, Nakagawa T, Saheki A, Sonoke S, Tomii Y . Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations. Int J Pharm. 2003; 267(1-2):101-12. DOI: 10.1016/j.ijpharm.2003.08.002. View